Reported Standalone quarterly numbers for Mangalam Drugs & Organics are:
Net Sales at Rs 48.58 crore in December 2018 down 34.27% from Rs. 73.91 crore in December 2017.
Story continues below Advertisement
Quarterly Net Loss at Rs. 4.42 crore in December 2018 down 173.92% from Rs. 5.98 crore in December 2017.
EBITDA stands negative at Rs. 0.95 crore in December 2018 down 107.16% from Rs. 13.26 crore in December 2017.
Mangalam Drugs shares closed at 55.40 on February 11, 2019 (NSE) and has given -47.39% returns over the last 6 months and -66.94% over the last 12 months.
Story continues below Advertisement
| Mangalam Drugs & Organics | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'18 | Sep'18 | Dec'17 | | Net Sales/Income from operations | 48.58 | 71.90 | 73.91 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 48.58 | 71.90 | 73.91 | | EXPENDITURE | | Consumption of Raw Materials | 39.51 | 54.71 | 55.91 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -7.84 | -6.58 | -10.05 | | Power & Fuel | -- | -- | -- | | Employees Cost | 6.37 | 6.43 | 5.63 | | Depreciation | 1.83 | 1.81 | 1.48 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 11.54 | 11.79 | 9.81 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -2.83 | 3.73 | 11.14 | | Other Income | 0.05 | 0.04 | 0.64 | | P/L Before Int., Excpt. Items & Tax | -2.78 | 3.77 | 11.78 | | Interest | 2.30 | 1.74 | 2.50 | | P/L Before Exceptional Items & Tax | -5.08 | 2.03 | 9.28 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -5.08 | 2.03 | 9.28 | | Tax | -0.66 | 0.30 | 3.30 | | P/L After Tax from Ordinary Activities | -4.42 | 1.73 | 5.98 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -4.42 | 1.73 | 5.98 | | Equity Share Capital | 15.83 | 15.83 | 15.83 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.79 | 1.09 | 3.78 | | Diluted EPS | -2.79 | 1.09 | 3.78 | | EPS After Extra Ordinary | | Basic EPS | -2.79 | 1.09 | 3.78 | | Diluted EPS | -2.79 | 1.09 | 3.78 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
